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Background: Untreated autoimmune hepatitis (AIH) can develop into liver cirrhosis, 
with potentially fatal outcomes. Viral hepatitis in children was endemic in Taiwan 
before universal hepatitis B vaccination, but AIH has rarely been reported in Taiwanese 
children. We performed this retrospective study to characterize the clinical fea-
tures of AIH in Taiwanese children.
Methods: We enrolled children with AIH, based on the revised scoring system of the 
International Autoimmune Hepatitis Group (IAIHG) from 383 children hospitalized with 
hepatitis from January 2000 to April 2008. Other etiologies of hepatitis were excluded. 
Results: There were three definite and six probable AIH cases. The incidence of AIH 
among children hospitalized with hepatitis was 2.3%. Eight children had other autoim-
mune diseases, including systemic lupus erythematosus (SLE) (6), discoid lupus erythe-
matosus (DLE) (1), and autoimmune polyendocrinopathy syndrome type 1 (1). Another 
had biliary atresia, and AIH developed after cadaveric liver transplantation. Antinuclear 
antibodies ranged from 1:160−1:2560. Peak alanine aminotransferase (ALT) values 
were 546 ± 188 U/L (mean ± SD). Jaundice occurred in four patients. Liver histology in 
the three definite AIH patients showed chronic hepatitis with predominantly lympho-
plasmacytic infiltrates in portal areas, with prominent interface activity. Treatment 
included prednisolone, azathioprine, and/or cyclosporine. All patients survived. ALT 
fell to < 60 U/L after treatment. Hepatitis relapse occurred in one patient.
Conclusion: AIH in Taiwanese children is commoner than previously thought. It is 
associated with other autoimmune diseases and may occur before, simultaneously 
with, or after other autoimmune diseases. Children with liver transplants are also 
at risk of AIH. 
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1. Introduction
Autoimmune hepatitis (AIH) is a chronic necroin-
flammatory hepatitis, which is characterized his-
tologically by dense mononuclear and plasma cell 
infiltrates in the portal tracts, and serologically 
by the presence of autoantibodies. AIH has been 
described since the early 1950s, but its etiology 
remains unknown.1 Without treatment, AIH may 
develop into cirrhosis of the liver, with potentially 
fatal outcomes. One prospective study reported 
mortality as high as 29.4% within 6 months.2 
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In contrast, improvements were found in 77.8% of 
AIH cases treated with prednisone 20 mg daily, with 
no deaths occurring within 6 months.2 Early diag-
nosis and prompt intervention are thus important 
to save lives. The mortality associated with AIH in 
children was 8% in Australia and 11% in the UK.3,4 
Taiwan was an endemic area for viral hepatitis in 
children before the introduction of universal hepa-
titis B virus vaccination, though AIH has rarely been 
reported in Taiwanese children. It is possible that 
it has been under-recognized, or it may genuinely 
be very rare. We performed this retrospective study 
to clarify the situation and characterize the clinical 
features of AIH in Taiwanese children.
2. Subjects and Methods
We reviewed data from children (≤ 18 years old) 
with a diagnosis of hepatitis hospitalized in the 
National Taiwan University Hospital from January 
2000 to April 2008. Patients with viral hepatitis, 
drug-induced hepatitis, extrahepatic obstructive 
diseases, nonalcoholic fatty liver disease, or meta-
bolic diseases were excluded. The liver histology 
of patients with suspected AIH was reviewed by a 
pathologist (YM Jeng). The revised scoring system 
proposed by the International Autoimmune Hepatitis 
Group (IAIHG) in 1999 was applied for the diagnosis 
of AIH.5−7 Patients with scores > 10 before treatment 
and/or > 12 after treatment were enrolled in this 
study. A definite diagnosis of AIH was made when 
the liver histology was compatible with the descrip-
tive criteria and scores were > 15 before treatment 
and/or > 17 points after treatment.6,8 Otherwise, 
a diagnosis of probable AIH was made.
3. Results
Nine patients (2.3%) were enrolled from the 383 
children hospitalized with a diagnosis of hepatitis 
from January 2000 to April 2008 (Table 1). Their 
clinical features, the presence of other autoim-
mune diseases, and treatment of AIH are shown in 
Table 2. Their peak alanine aminotransferase (ALT) 
levels are summarized in Table 3. Liver histology in 
the three definite AIH patients showed chronic hep-
atitis with predominantly lymphoplasmacytic infil-
trates in portal areas, with prominent interface 
activity (Figures 1A and 1B).
Only one patient had no other concurrent au-
toimmune disease. This was a girl with biliary atresia 
who had undergone cadaveric liver transplantation 
at the age of 11 months. Only one patient had AIH 
before developing another systemic autoimmune 
disease. She developed malar rash, arthralgia, oral 
ulcers, and pancytopenia 1 month after a definite 
diagnosis AIH, and finally fulfilled the criteria for 
systemic lupus erythematosus (SLE). One patient 
with discoid lupus erythematosus (DLE) and two 
with SLE had abnormal liver function tests simulta-
neously with their first presentations with other 
systemic autoimmune diseases. 
Treatment for AIH included prednisolone, aza-
thioprine, and/or cyclosporine. ALT decreased to 
< 60 U/L after 15−138 days of treatment (median: 
40 days). All the patients survived during follow-up. 
Relapse of AIH activity was noted 4 years after the 
first episode in the patient with biliary atresia 
post-liver transplantation. Her ALT increased to 
439 U/L after prednisolone was tapered from 5 mg 
daily to 5 mg every other day, over a 2-month pe-
riod. Her ALT decreased to 55 U/L after 170 days of 
treatment with prednisolone increased to 30 mg 
daily. She took prednisolone 5 mg daily as mainte-
nance therapy thereafter.
4. Discussion
The incidence of AIH in western European popula-
tions ranges from 0.69−1.9 per 100,000 per year, 
and prevalences of 8.0 per 100,000 in Iceland and 
16.9 per 100,000 in Norway have been reported.9 
A Taiwanese study revealed that the annual incidence 
of AIH in adults was 0.52 per 100,000 per year in 
Tainan County.10 The relative number of cases of AIH 
among patients with chronic active hepatitis is low 
in regions with a high prevalence of viral hepatitis. 
AIH was estimated to account for 1% of patients with 
Table 1  Children (≤ 18 years old) admitted to the 
National Taiwan University Hospital from 
January 2000 to April 2008 with a diagnosis 
of hepatitis were classified according to the 
International Classification of Diseases, Ninth 
Revision (ICD-9)
Disease ICD-9 
Patient
  no.
Hepatitis, unspecified* 573.3 130
Chronic hepatitis† 571.4  18
Viral hepatitis 70 108
Acute or subacute hepatitis, 570  66
 not specified as infective
Neonatal hepatitis 774.4  47
Hepatitis in viral diseases 573.1  14
Total  383
*There were four probable cases of autoimmune hepatitis 
(AIH) among the 130 patients with a diagnosis of hepatitis, 
unspecified (3.1%). †There were three definite and two prob-
able cases of AIH among the 18 patients with a diagnosis of 
chronic hepatitis (27.8%).
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chronic active hepatitis in Hong Kong, less than 5% in 
Japan, approximately 20% in the white populations 
of western Europe and North America, and 62% 
in Australia.9 In the Pediatric Liver Unit of King’s 
College Hospital, London, the relative incidence of 
autoimmune liver disease was 2.3% among 822 re-
ferred children older than 4 months, between 1991 
and 1993.4 In our study, AIH was diagnosed in nine of 
383 (2.3%) children hospitalized with a diagnosis of 
hepatitis from January 2000 to April 2008. This ratio 
was higher than expected. This could be because the 
prevalence of hepatitis B surface antigen among 
children younger than 15 years in Taiwan fell from 
9.8% in 1984 to 0.7% in 1999, after the introduction 
of universal hepatitis B virus vaccination in 1984.11
In a UK study, the prevalence of AIH was 9.8% 
(9/92) in juvenile SLE patients and 1.1% (4/377) in 
adult SLE patients.12 Chinese have a higher preva-
lence of SLE than Caucasians, Malays, Indians, and 
other Asians.13,14 However, the prevalence of AIH 
appears to be lower in Taiwanese SLE patients than 
in Caucasian ones. To the best of our knowledge, 
there has been only one report of a Taiwanese adult 
SLE patient simultaneously diagnosed with AIH.15 
None of the 48 adult AIH patients in the above 
mentioned Taiwanese study had SLE.10 A previous 
Taiwanese report described one pediatric SLE 
patient with AIH, and another 48 pediatric SLE 
patients without AIH, between 1983 and 1995.16 
The relatively low prevalence of AIH in Taiwanese 
SLE patients might be due to ethnic differences or 
to under-diagnosis of AIH.
The incidence of SLE in AIH patients in the cur-
rent study (67%) was much higher than that in the 
western studies (< 7%).3,4 In a UK study, AIH pre-
ceded SLE manifestations in all of nine children 
over an average period of 22 months.12 However, 
only one of our patients had AIH before SLE. This 
could also be due to ethnic differences or to under-
diagnosis of AIH in Taiwanese children with no other 
precedent autoimmune diseases. The introduction 
of a test to detect anti-liver-kidney microsomal 
antibodies (anti-LKM1) would be helpful for the di-
agnosis of type 2 AIH.17 It is noteworthy that au-
toantibody titers tend to be lower in children than 
in adults with AIH. A single low autoantibody titer 
cannot exclude a diagnosis of AIH, but any positive 
titer, combined with other factors, is sufficient to 
support a definite diagnosis.17 
The clinical presentation and increases in ALT 
levels tend to be more severe in pediatric SLE 
patients with AIH than in pediatric SLE patients 
without AIH. In the above mentioned Taiwanese 
study, eight (16.7%) of 48 pediatric SLE patients 
had abnormal laboratory liver function tests. The 
highest level of ALT was 310 U/L, and none had jaun-
dice or hepatosplenomegaly.16 Here, five (83.3%) 
pediatric SLE patients with AIH had ALT levels 
> 310 U/L, and three (50%) had jaundice.
AIH may occur after liver transplantation in 
children with no previous history of autoimmune 
hepatitis, and the reported risk (2.5%) is greater 
than that for the general pediatric population.18 In 
our study, one patient developed de novo AIH 8 years 
after liver transplantation, and relapsed 4 years 
after the first episode.
A B
Figure (A) Liver histology of the first definite autoimmune hepatitis patient showing chronic active hepatitis (hema-
toxylin and eosin stain, ×200). (B) Magnification showing predominant lymphoplasma cell infiltration in the portal 
area with focal piecemeal necrosis (hematoxylin and eosin stain, ×400).
Table 3  Peak alanine aminotransferase levels in 
Taiwanese children with AIH 
Peak ALT (U/L) Case no. (%)
< 300 1 (11)
300−600 3 (33)
> 600 5 (56)
Mean ± SD, 546 ± 188 9 (100)
ALT = alanine aminotransferase.
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In summary, viral hepatitis in children was pre-
viously endemic in Taiwan, but AIH in children here 
is not as rare as previously thought. It is highly as-
sociated with other autoimmune diseases and can 
occur before, simultaneously with, or after the de-
velopment of other autoimmune diseases. Children 
with liver transplants are also at increased risk of 
AIH. An awareness of AIH in Taiwanese children is 
important for differential diagnosis and for plan-
ning appropriate interventions in patients with 
chronic hepatitis and noninfectious hepatitis.
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